Pharmaceutical

The pharmaceutical industry has witnessed a dramatic decline in deal activity, reaching its lowest point in nearly a decade as major drugmakers pivot away from commercially ready medicines towards early-stage drug development investments.…

A significant move in the pharmaceutical investment landscape has emerged as Carlyle-backed Abingworth seeks to raise up to £1.5 billion for clinical trials funding, marking a strategic shift towards royalty-based partnerships with major…

AstraZeneca's chief executive, Sir Pascal Soriot, has disclosed that former employees in China breached company protocols by using WeChat messaging services, amidst ongoing investigations by Chinese authorities. The revelation comes as the…

Market observers are keenly awaiting SSE's interim results this Wednesday, with particular focus on the FTSE 100 energy group's spending strategies. The company, a dominant force in UK offshore wind development, has recently achieved…

Pharmaceutical giant AbbVie witnessed a devastating blow to its market value today as shares plummeted following disappointing clinical trial results for its experimental schizophrenia treatment, Emraclidine. The Chicago-based…

Danish pharmaceutical giant Novo Nordisk has reported exceptional third-quarter results, driven by remarkable sales of its weight-loss treatment Wegovy. The anti-obesity medication generated sales of 17.3 billion Danish krone (£1.96…

In a significant development for the global pharmaceutical sector, AstraZeneca's leading executive in China, Leon Wang, has been detained by Chinese authorities, marking an escalation in the ongoing probe into the company's operations in…

AstraZeneca, one of the world's leading pharmaceutical companies, experienced a significant setback on Tuesday as its stock price plummeted, wiping out £15 billion in market value. This dramatic drop was triggered by a combination of…

Recent breakthrough research from Denmark's Aarhus University has sparked significant market interest in the pharmaceutical sector, particularly concerning exercise mimetics. The discovery of LaKe, a compound purported to replicate the…

A concerning trend in cancer diagnoses among young adults has sparked a significant £20 million global research initiative. Data from the UK reveals cancer cases in individuals under 50 are rising at twice the rate compared to elderly…

British pharmaceutical giant GSK has held firm on its annual group forecasts despite experiencing a decline in vaccine sales, with strong performance in specialist medicines helping to offset the downturn. The FTSE 100 company reported a 2%…

A revolutionary combination of three drugs has demonstrated remarkable success in doubling survival times for patients battling incurable breast cancer, according to a landmark clinical trial. The research, spearheaded by the Institute of…

The French government warned a US-based private equity firm that was buying the consumer healthcare division of Sanofi, that it would face penalties exceeding EUR100m for not keeping production and jobs in France. Sanofi is separating…

In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy and import…

A recent study has highlighted concerning practices in animal research facilities that may worsen the global crisis of antimicrobial resistance. Published in the journal *Plos One*, the research indicates that antibiotic use in laboratory…

The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy, has shown…

The Delaware Supreme Court has agreed to hear an appeal by GSK and other pharmaceutical giants, including Pfizer, Sanofi, and Boehringer Ingelheim, in their bid to halt more than 70,000 lawsuits alleging that the discontinued heartburn…

In a groundbreaking pilot study, researchers have introduced an innovative approach to deep brain stimulation (DBS) that may greatly enhance the lives of individuals with Parkinson's disease. This technique, referred to as "adaptive" DBS,…